Weight loss and hormone pill tested for fertility-sparing cancer treatment – but trial stopped early
NCT ID NCT05316467
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether combining weight management (diet and exercise guidance) with a daily hormone pill (megestrol acetate) could help obese patients with early-stage endometrial cancer who want to preserve their fertility. The goal was to see if the cancer would completely respond within 28 weeks. However, the trial was terminated early and only enrolled 8 people, so we cannot draw strong conclusions from it.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Megestrol acetate (a hormone drug) plus intensive lifestyle intervention (diet and exercise guidance)
- What this could lead to
- If it had succeeded, this approach could have offered a way to control early endometrial cancer while preserving fertility in obese patients.
- What could go wrong
- The trial was terminated early with only 8 participants, so results are very limited. It is unclear if the combination works better than standard treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY-STAGE ENDOMETRIOID CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Obstetrics and Gynecology Hospital, Fudan University
Shanghai, Shanghai Municipality, 200011, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Drug combo tip the scales against obesity?
- Does when you eat carbs and protein reshape blood sugar control?
- Can a weekly shot keep metabolism from slowing after weight loss?
- Can Early-Life factors steer preterm and term infant health?
- Can a new injection help tackle obesity? a trial investigates
- Can a new injection help shed pounds? a trial investigates